Kanagawa, Japan

Naoyoshi Noguchi


 

 

Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Fujisawa, JP (2017)
  • Kanagawa, JP (2021 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Naoyoshi Noguchi: Innovator in Pharmaceutical Compounds

Introduction

Naoyoshi Noguchi is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target various diseases. With a total of four patents to his name, his work is recognized for its potential therapeutic applications.

Latest Patents

One of Noguchi's latest patents is for a macrocyclic compound that exhibits NRF2 activating activity. This compound is expected to be useful as a preventive or therapeutic agent for diseases associated with oxidative stress, including hepatic diseases like non-alcoholic steatohepatitis (NASH), cardiovascular diseases such as heart failure, and lung diseases like chronic obstructive pulmonary disease (COPD). Additionally, he has developed an aromatic compound that may have GPR40 agonist activity and GLP-1 secretagogue action, which could be beneficial in treating conditions like cancer, obesity, diabetes, and metabolic syndrome.

Career Highlights

Throughout his career, Naoyoshi Noguchi has worked with notable companies, including Takeda Pharmaceutical Company Limited and Scohia Pharma, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

He has collaborated with esteemed colleagues such as Jumpei Aida and Yuko Hitomi, contributing to the advancement of research in his field.

Conclusion

Naoyoshi Noguchi's innovative work in developing pharmaceutical compounds showcases his commitment to addressing critical health issues. His contributions are expected to have a lasting impact on the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…